TearLab prices $35.1 mil public offering of common stock

Article

 

San Diego-TearLab Corp. announced the pricing of an underwritten public offering of 2,600,000 shares of its common stock at a price to the public of $13.50 per share for gross proceeds of $35.1 million.

Net proceeds from the sale of the shares will be approximately $32.6 million.  TearLab has also granted the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover overallotments.

TearLab plans to use the net proceeds from this offering for commercialization of its products, research and development, working capital, and other general corporate purposes. The offering is expected to close on or about July 30, subject to the satisfaction of customary closing conditions.

Recent Videos
Ben Casella, OD, FAAO, giving a reminder for eye care providers to register for EyeCon 2024.
Dr. Brian Lojka chats about strabismus in athletes
Jack Chapman, MD, talks best candidates for light adjustable lenses.
Diabetic eye care expert A. Paul Chous, OD, MA, FAAO, shares insights on patient care and research
Katherine Talcott, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.